Literature DB >> 21805256

Muscle biopsy.

G Meola1, E Bugiardini, R Cardani.   

Abstract

Muscle biopsy is required to provide a definitive diagnosis in many neuromuscular disorders. It can be performed through an open or needle technique under local anesthesia. The major limitations of the needle biopsy technique are the sample size, which is smaller than that obtained with open biopsy, and the impossibility of direct visualization of the sampling site. However, needle biopsy is a less invasive procedure than open biopsy and is particularly indicated for diagnosis of neuromuscular disease in infancy and childhood. The biopsied muscle should be one affected by the disease but not be too weak or too atrophic. Usually, in case of proximal muscle involvement, the quadriceps and the biceps are biopsied, while under suspicion of mitochondrial disorder, the deltoid is preferred. The samples must be immediately frozen or fixed after excision to prevent loss of enzymatic reactivity, DNA depletion or RNA degradation. A battery of stainings is performed on muscle sections from every frozen muscle biopsy arriving in the pathology laboratory. Histological, histochemical, and histoenzymatic stainings are performed to evaluate fiber atrophy, morphological, and structural changes and metabolic disorders. Moreover, immunohistochemistry and Western blotting analysis may be used for expression analysis of muscle proteins to obtain a specific diagnosis. There are myopathies that do not need muscle biopsy since a genetic test performed on a blood sample is enough for definitive diagnosis. Muscle biopsy is a useful technique which can make an enormous contribution in the field of neuromuscular disorders but should be considered and interpreted together with the patient's family and clinical history.

Entities:  

Mesh:

Year:  2011        PMID: 21805256     DOI: 10.1007/s00415-011-6193-8

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  43 in total

Review 1.  The diagnosis of mitochondrial muscle disease.

Authors:  Robert W Taylor; Andrew M Schaefer; Martin J Barron; Robert McFarland; Douglass M Turnbull
Journal:  Neuromuscul Disord       Date:  2004-04       Impact factor: 4.296

2.  Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy.

Authors:  R Cardani; E Mancinelli; V Sansone; G Rotondo; G Meola
Journal:  Eur J Histochem       Date:  2004 Oct-Dec       Impact factor: 3.188

3.  Increase in percutaneous muscle biopsy yield with a suction-enhancement technique.

Authors:  J V Hennessey; J A Chromiak; S Della Ventura; J Guertin; D B MacLean
Journal:  J Appl Physiol (1985)       Date:  1997-06

Review 4.  Pathology of the inflammatory myopathies.

Authors:  G Karpati; S Carpenter
Journal:  Baillieres Clin Neurol       Date:  1993-11

5.  Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies.

Authors:  A M Emslie-Smith; K Arahata; A G Engel
Journal:  Hum Pathol       Date:  1989-03       Impact factor: 3.466

6.  STIR MRI to direct muscle biopsy in suspected idiopathic inflammatory myopathy.

Authors:  Andrew Connor; Simon Stebbings; Noelyn Anne Hung; Graeme Hammond-Tooke; Grant Meikle; John Highton
Journal:  J Clin Rheumatol       Date:  2007-12       Impact factor: 3.517

7.  New methods for molecular diagnosis and demonstration of the (CCTG)n mutation in myotonic dystrophy type 2 (DM2).

Authors:  R Sallinen; A Vihola; L L Bachinski; K Huoponen; H Haapasalo; P Hackman; S Zhang; M Sirito; H Kalimo; G Meola; N Horelli-Kuitunen; M Wessman; R Krahe; B Udd
Journal:  Neuromuscul Disord       Date:  2004-04       Impact factor: 4.296

Review 8.  Pathological defects in congenital myopathies.

Authors:  Caroline A Sewry
Journal:  J Muscle Res Cell Motil       Date:  2008-12-30       Impact factor: 2.698

9.  Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.

Authors:  J D Brook; M E McCurrach; H G Harley; A J Buckler; D Church; H Aburatani; K Hunter; V P Stanton; J P Thirion; T Hudson
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

10.  Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy.

Authors:  C Minetti; F Sotgia; C Bruno; P Scartezzini; P Broda; M Bado; E Masetti; M Mazzocco; A Egeo; M A Donati; D Volonte; F Galbiati; G Cordone; F D Bricarelli; M P Lisanti; F Zara
Journal:  Nat Genet       Date:  1998-04       Impact factor: 38.330

View more
  10 in total

Review 1.  High-resolution 3D tractography of fibrous tissue based on polarization-sensitive optical coherence tomography.

Authors:  Gang Yao; Dongsheng Duan
Journal:  Exp Biol Med (Maywood)       Date:  2019-12-08

Review 2.  Muscle biopsy evaluation in neuromuscular disorders.

Authors:  Nanette C Joyce; Björn Oskarsson; Lee-Way Jin
Journal:  Phys Med Rehabil Clin N Am       Date:  2012-08       Impact factor: 1.784

Review 3.  Biomolecular diagnosis of myotonic dystrophy type 2: a challenging approach.

Authors:  Giovanni Meola; Fiammetta Biasini; Rea Valaperta; Elena Costa; Rosanna Cardani
Journal:  J Neurol       Date:  2017-05-26       Impact factor: 4.849

4.  Assessment of Premutation in Myotonic Dystrophy Type 1 Affected Family Members by TP-PCR and Genetic Counseling.

Authors:  Ashok Kumar; Sarita Agarwal; Sunil Pradhan
Journal:  Case Rep Med       Date:  2014-02-23

5.  Differences in pain perception during open muscle biopsy and Bergstroem needle muscle biopsy.

Authors:  Julius Dengler; Peter Linke; Hans J Gdynia; Stefan Wolf; Albert C Ludolph; Peter Vajkoczy; Thomas Meyer
Journal:  J Pain Res       Date:  2014-11-17       Impact factor: 3.133

6.  Myotonic Dystrophy Type 2: An Update on Clinical Aspects, Genetic and Pathomolecular Mechanism.

Authors:  Giovanni Meola; Rosanna Cardani
Journal:  J Neuromuscul Dis       Date:  2015-07-22

Review 7.  What Every Neuropathologist Needs to Know: The Muscle Biopsy.

Authors:  James S Nix; Steven A Moore
Journal:  J Neuropathol Exp Neurol       Date:  2020-07-01       Impact factor: 3.685

8.  The clinical spectrum and genetic variability of limb-girdle muscular dystrophy in a cohort of Chinese patients.

Authors:  Liang Wang; Victor Wei Zhang; Shaoyuan Li; Huan Li; Yiming Sun; Jing Li; Yuling Zhu; Ruojie He; Jinfu Lin; Cheng Zhang
Journal:  Orphanet J Rare Dis       Date:  2018-08-14       Impact factor: 4.123

9.  RNA-seq in DMD urinary stem cells recognized muscle-related transcription signatures and addressed the identification of atypical mutations by whole-genome sequencing.

Authors:  Maria S Falzarano; Andrea Grilli; Silvia Zia; Mingyan Fang; Rachele Rossi; Francesca Gualandi; Paola Rimessi; Reem El Dani; Marina Fabris; Zhiyuan Lu; Wenyan Li; Tiziana Mongini; Federica Ricci; Elena Pegoraro; Luca Bello; Andrea Barp; Valeria A Sansone; Madhuri Hegde; Barbara Roda; Pierluigi Reschiglian; Silvio Bicciato; Rita Selvatici; Alessandra Ferlini
Journal:  HGG Adv       Date:  2021-08-24

10.  Muscle Biopsy: A Requirement for Precision Medicine in Adult-Onset Myopathy.

Authors:  Meng-Ju Wu; Wei-An Liao; Po-Yu Lin; Yuan-Ting Sun
Journal:  J Clin Med       Date:  2022-03-13       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.